Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer

Daniel Canteros; Benjamín Walbaum; Miguel Córdova‐Delgado; Andrés TORREALBA; Constanza Reyes; María Elena Navarro; Dravna Razmilic; Mauricio Camus; Francisco Domı́nguez; Orieta Navarrete; Mauricio P. Pinto; Gonzalo Pizarro; Francisco Acevedo

doi:10.3332/ecancer.2022.1396

JOURNAL ARTICLE

Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer

Daniel Canteros Benjamín Walbaum Miguel Córdova‐Delgado Andrés TORREALBA Constanza Reyes María Elena Navarro Dravna Razmilic Mauricio Camus Francisco Domı́nguez Orieta Navarrete Mauricio P. Pinto Gonzalo Pizarro Francisco Acevedo

Year: 2022 Journal: ecancermedicalscience Vol: 16 Pages: 1396-1396 Publisher: Cancer Intelligence

DOI: 10.3332/ecancer.2022.1396

Get Full-Text PDF Get Analytical Report

Abstract

CEM is a reliable alternative to high-cost, time-consuming breast MRI that predicts pCR in patients undergoing NACT; CEM diagnostic accuracy was higher among patients who harboured HR- tumours.

Keywords:

Medicine Logistic regression Breast cancer Pathological Mammography Multivariate analysis Receiver operating characteristic Univariate Univariate analysis Magnetic resonance imaging Neoadjuvant therapy Oncology Internal medicine Radiology Multivariate statistics Cancer

Metrics

Cited By

0.68

FWCI (Field Weighted Citation Impact)

Refs

0.57

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Breast Cancer Treatment Studies

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

Global Cancer Incidence and Screening

Health Sciences → Medicine → Oncology

Breast Lesions and Carcinomas

Health Sciences → Medicine → Pathology and Forensic Medicine

Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer

Abstract

Metrics

Citation History

Topics

Related Documents

Pathological complete response in locally advanced breast cancer after neoadjuvant chemotherapy

Role of contrast enhanced spectral mammography in predicting pathological response of locally advanced breast cancer post neo-adjuvant chemotherapy

Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy

Clinical and pathological response to neoadjuvant chemotherapy with different chemotherapy regimens predicts the outcome of locally advanced breast cancer

Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer